AKT1 and cancer: In a large panel of cancer cell lines, T-cell acute lymphoblastic leukemia (T-ALL) with Notch mutation were highly sensitive to Akt inhibitor (AZD5363) and the mTORC1/2 inhibitor (AZD2014) but only partially sensitive to PI3K inhibitors [325].